Genomic instability in drug-resistant human melanoma cell lines detected by Alu-I-arbitrary-primed PCR

Anticancer Research

Volumn 23, Issue 3 B, 2003, Pages 2601-2608

  Brkic, Gordana ^a   Gopas, Jacob ^a,b   Tanic, Nicola ^c   Dedovic Tanic, Nasta ^c   Benharroch, Daniel ^b   Finkelstein Jaworowsky, Eve ^b   Kedar, Igar ^b   Dimitrijevic, Bogomir ^c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Alu I arbitrary primed PCR (Alu IAP PCR); Genomic instability; Melanoma; Retroviral LTR sequences

Indexed keywords

CARMUSTINE; CELL ADHESION MOLECULE; DOXORUBICIN; GENOMIC DNA; METHYLNITRONITROSOGUANIDINE; TIOGUANINE;

ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DNA SEQUENCE; GENOME; HUMAN; HUMAN CELL; INTRON; LONG TERMINAL REPEAT; MELANOMA CELL; MICROSATELLITE INSTABILITY; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0042306459     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Lengauer C, Kinzler KW and Vogelstein B: Genetic instabilities in human cancer. Nature 396: 643-649, 1998.
2. Cahill DP, Kinzler KW, Vogelstein B and Lengauer C: Genetic instability and darwinian selection in tumours. Trends Cell Biol 9: 57-60, 1999.
3. Breivik J: Don't stop for repairs in a war zone: Darwinian evolution unites genes and environment in cancer development. Proc Natl Acad Sci USA 98: 5379-5381, 2001.
4. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW and Vogelstein BV: Mutations of mitotic checkpoint genes in human cancers. Nature 392: 300-303, 1998.
5. Cahill DP, da Costa LT, Carson-Walter EB, Kinzler KW, Vogelstein B and Lengauer C: Characterization of MAD2B and other mitotic spindle checkpoint genes. Genomics 58: 181-187, 1999.
6. Breivik J and Gaudernack G: Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis. Semin Cancer Biol 9: 245-254, 1999.
7. Lengauer C, Kinzler KW and Vogelstein B: DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci USA 94: 2545-2550, 1997.
8. Duesberg P, Stindl R and Hehlmann R: Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy. Proc Natl Acad Sci USA 97: 14295-14300, 2000.
9. Li R, Sonik A, Stindl R, Rasnick D and Duesberg P: Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy Proc Natl Acad Sci USA 97: 3236-4321, 2000.
10. Li R, Yerganian G, Duesberg P, Kraemer A, Willer A, Rausch C and Hehlmann R: Aneuploidity correlated 100% with chemical transformation of Chinese hamster cells. Proc Natl Acad Sci USA 94: 14506-14511, 1997.
11. Perucho M. Correspondence re: C.R. Boland et al: A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257, 1998.
12. Wang TL, Rago C, Silliman N, Ptak J, Markowitz S, Willson JK, Parmigiani G, Kinzler KW, Vogelstein B and Velculescu VE: Prevalence of somatic alterations in the colorectal cancer cell genome. Proc Natl Acad Sci USA 99: 3076-3080, 2002.
13. Helmbach H, Rossmann E, Kern MA and Schadendorf D: Drug-resistance in human melanoma. Int J Cancer 93: 617-622, 2001.
14. Balaban G, Herlyn M, Guerry D 4th, Bartolo R, Koprowski H, Clark WH and Nowell PC: Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet Cytogenet 11: 429-439, 1984.
15. Balaban GB, Herlyn M, Clark WH Jr and Nowell PC: Karyotypic evolution in human malignant melanoma. Cancer Genet Cytogenet 19: 113-122, 1986.
16. Thompson FH, Emerson J, Olson S, Weinstein R, Leavitt SA, Leong SP, Emerson S, Trent JM, Nelson MA, Salmon SE et al: Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypes. Cancer Genet Cytogenet 83: 93-104, 1995.
17. Nelson MA, Radmacher MD, Simon R, Aickin M, Yang J, Panda L, Emerson J, Roe D, Adair L, Thompson F, Bangert J, Leong SP, Taetle R, Salmon S and Trent J: Chromosome abnormalities in malignant melanoma: clinical significance of nonrandom chromosome abnormalities in 206 cases. Cancer Genet Cytogenet 122: 101-109, 2000.
18. Wiltshire RN, Dennis TR, Sondak VK, Meltzer PS and Trent JM: Application of molecular cytogenetic techniques in a case study of human cutaneous metastatic melanoma. Cancer Genet Cytogenet 131: 97-103, 2001.
19. Guan XY, Zhang HE, Zhou H, Sham JS, Fung JM and Trent JM: Characterization of a complex chromosome rearrangement involving 6q in a melanoma cell line by chromosome microdissection. Cancer Genet Cytogenet 134: 65-70, 2002.
20. Saida T: Recent advances in melanoma research. J Dermatol Sci 26: 1-13, 2001.
21. Pollock PM and Trent JM: The genetics of cutaneous melanoma. Clin Lab Med 20:667-690, 2000.
22. Hussein MR, Sun M, Roggero E, Sudilovsky EC, Tuthill RJ, Wood GS and Sudilovsky O: Loss of heterozygosity, microsatellite instability and mismatch repair protein alterations in the radial growth phase of cutaneous malignant melanomas. Mol Carcinog 34: 35-44, 2002.
23. Li G, Satyamoorthy K and Herlyn M: N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 61: 3819-3825, 2001.
24. Maitra A, Gazdar AF, Moore TO and Moore AY: Loss of heterozygosity analysis of cutaneous melanoma and benign melanocytic nevi: laser capture microdissection demonstrates clonal genetic changes in acquired nevocellular nevi. Hum Pathol 33: 191-197, 2002.
25. Hussein MR and Wood GS: Microsatellite instability in human melanocytic skin tumors: an incidental finding or a pathogenetic mechanism? J Cutan Pathol 29: 1-4, 2002.
26. Hussein MR, Sun M, Tuthill RJ, Roggero E, Monti JA, Sudilovsky EC, Wood GS and Sudilovsky O: Comprehensive analysis of 112 melanocytic skin lesions demonstrates microsatellite instability in melanomas and dysplastic nevi, but not in benign nevi. J Cutan Pathol 28: 343-50, 2001.
27. Alvino E, Marra G, Pagani E, Falcinelli S, Pepponi R, Perrera C, Haider R, Castiglia D, Ferranti G, Bonmassar E, Jiricny J, Zambruno G and D'Atri S: High-frequency microsatellite instability is associated with defective DNA mismatch repair in human melanoma. J Invest Dermatol 118: 79-86 2002.
28. Nessling M, Kern MA, Schadendorf, D and Lichter P: Association of genomic imbalances with resistance to therapeutic drugs in human melanoma cell lines. Cytogenet Cell Genet 87: 286-290, 1999.
29. Lage H, Christmann M, Kern MA, Dietel M, Pick M, Kaina B and Schadendorf D: Expression of DNA repair proteins hMSH2, hMSH6, hMLH1, O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in melanoma cells with acquired drug resistance. Int J Cancer 80: 744-750, 1999.
30. Runger TM, Emmert S, Schadendorf D, Diem C, Epe B and Hellfritsch D: Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide. J Invest Dermatol 114: 34-39, 2000.
31. McClelland M and Welsh J: DNA fingerprinting by arbitrarily primed PCR. PCR Methods Appl 4: S59-65, 1994.
32. Sood AK and Buller RE: Genomic instability in ovarian cancer: a reassessment using an arbitrarily primed polymerase chain reaction Oncogene 13: 2499-2504, 1996.
33. Cobb B: Optimisation of RAPD fingerprinting. In: Finerprinting Methods Based on Arbitrarily Primed PCR (Parthier B and Bouther, eds). Berlin, Springer, 1997, pp.46-47.
34. Arcot SS, Wang Z, Weber JL, Deininger, PL and Batzer MA: Alu repeats: a source for the genesis of primate microsatellites. Genomics 29: 136-144, 1995.
35. Sathiyamoorthy P, Lugasi-Evgi H, Schlesinger P, Kedar I, Gopas J, Pollack Y and Golan-Goldhirsh A: Screening for cytotoxic and antimalarial activities in desert plants of the Negev and Bedouin market plant products. Pharmaceutical Biology 37: 188-195, 1999.
36. Jonston MD, Fint ER and Young PA: Drug uptake method for assay of interferon activity. Methods in Enzymology 78: 394-399, 1981.
37. Rudin CM and Thompson CB: Transcriptional activation of short interspersed elements by DNA-damaging agents. Genes Chromosomes Cancer 30: 64-71, 2001.
38. Perucho M, Peinado MA, Ionov Y, Casares S, Malkhosyan S and Stanbridge E: Defects in replication fidelity of simple repeated sequences reveal a new mutator mechanism for oncogenesis. Cold Spring Harb Symp Quant Biol 59: 339-348, 1994.
39. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
40. Marx J: Debate surges over the origins of genomic defects in cancer. Science 297: 544-547, 2002.
41. Woodford-Richens KL, Rowan AJ, Gorman P, Halford S, Bicknell DC, Wasan HS, Roylance RR, Bodmer WF and Tomlinson IP: SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of microsatellite instability pathway. Proc Natl Acad Sci USA 98: 9719-9723, 2001.
42. Karran P: Mechanisms of tolerance to DNA damaging therapeutic drugs. Carcinogenesis 22: 1931-1937, 2001.
43. Wittig R, Nessling M, Will RD et al: Candidate genes for cross-resistance against DNA-damaging drugs. Cancer Res 62: 6698-6705, 2002.
44. Thies A, Schachner M, Moll I, Berger J, Schulze H, Brunner G and Schumacher U: Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. Eur J Cancer 38: 1708-1713, 2002.
45. Kowitz A, Kadmon G, Verschueren H, Remels L, De Baetselier P, Hubbe M, Schachner M, Schirrmacher V and Altevogt P: Expression of L1 cell adhesion molecule is associated with lymphoma growth and metastasis. Clin Exp Metastasis 1: 419-429, 1993.
46. Voura EB, Ramjeesingh RA, Montgomery AM and Siu CH: Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. Mol Biol Cell 12: 2699-2710, 2001.
47. Senner V, Kismann E, Puttmann S, Hoess N, Baur I and Paulus W: L1 expressed by glioma cells promotes adhesion but not migration. Glia 38: 146-154, 2002.
48. Griffiths DJ: Endogenous retroviruses in the human genome sequence. Genome Biol 2: 1017.1-1017.5, 2001.
49. Prak ET and Kazazian HH Jr: Mobile elements and the human genome. Nat Rev Genet 1: 134-144, 2000.
50. Nagayama J, Iino M, Tada Y, Kusaba H, Kiue A, Ohshima K, Kuwano M and Wada M: Retrovirus insertion and transcriptional activation of the multidrug-resistance gene in leukemias treated by a chemotherapeutic agent in vivo. Blood 97: 759-766, 2001.